Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017
Operating Activities
Net loss	$ (5,302,443)	$ (7,319,856)	$ (98,116)
Net income (loss) from discontinued operations	(1,267,344)	(1,536,159)	2,357,629
Net loss from continuing operations	(4,035,099)	(5,783,697)	(2,455,745)
Adjustments to reconcile net loss from continuing operations to net cash provided by (used in) operating activities:
Depreciation	367,492	136,761	151,235
Amortization	1,085,400	1,253,244	1,267,182
Provision for excess and obsolete inventories	681,925	175,712	307,811
Charge for lower of cost or net realizable value for inventories	656,323	246,053	126,822
Gain on disposal of property and equipment	(251,214)	(1,980)
Deferred income tax provision (benefit)		1,328,000	(463,000)
Share based compensation expense	199,292	155,174	175,465
Restructuring charge		449,845
(Gain) loss from equity method investment	(135,505)	258,558
Changes in operating assets and liabilities:
Accounts receivable	(1,419,580)	609,223	300,933
Unbilled revenue	(2,253,183)
Income tax receivable\payable	157,416	37,648	226,377
Inventories	(1,590,972)	(462,051)	(1,434,314)
Prepaid expenses and other assets	(205,516)	25,147	19,163
Accounts payable	180,256	868,779	760,908
Accrued expenses and other liabilities	477,042	36,909	132,166
Deferred revenue	97,478
Net cash used in operating activities – continuing operations	(5,988,445)	(666,675)	(884,997)
Net cash provided by operating activities – discontinued operations	1,179,876	4,492,109	3,873,810
Net cash provided by (used in) operating activities	(4,808,569)	3,825,434	2,988,813
Investing Activities
Acquisition of net operating assets	(1,264,058)		(6,643,540)
Proceeds from sale of business	753,199
Loan repayments from (investment in and loans to) equity method investee	184,505	(208,854)	2,389,920
Purchases of property and equipment	(601,612)	(127,257)	(140,680)
Disposals of property and equipment	452,245	13,500
Net cash used in investing activities – continuing operations	(475,721)	(322,611)	(4,394,300)
Net cash provided by (used in) investing activities – discontinued operations	7,075,000	10,400	(47,806)
Net cash provided by (used in) investing activities	6,599,279	(312,211)	(4,442,106)
Financing Activities
Change in bank revolving line of credit	(500,000)	500,000
Guaranteed payments for acquisition of business	(667,000)	(667,000)	(1,000,000)
Proceeds on notes payable			4,000,000
Debt issuance costs			(16,300)
Payments on notes payable	(1,496,279)	(4,005,658)	(1,881,802)
Principal payments on capital lease obligations	(64,753)
Net cash provided by (used in) financing activities – continuing operations	(2,728,032)	(4,172,658)	1,101,898
Net cash used in financing activities – discontinued operations	(597,906)	(184,008)	(184,008)
Net cash provided by (used in) financing activities	(3,325,938)	(4,356,666)	917,890
Net decrease in cash and cash equivalents and restricted cash	(1,535,228)	(843,443)	(535,403)
Cash and cash equivalents and restricted cash at beginning of year	3,129,280	3,972,723	4,508,126
Cash and cash equivalents and restricted cash at end of year	1,594,052	3,129,280	3,972,723
Supplemental cash flow information:
Cash paid for interest	126,059	220,117	360,805
Cash received from income taxes	(172,343)	(59,674)	(61,000)
Supplemental noncash investing activities:
Deferred guaranteed payments for acquisition of business			(1,836,105)
Promissory note from disposition of business	$ 6,375,000